Transcranial Electrical Stimulation for Mal de Debarquement Syndrome

NCT02540616 — Not applicable, Withdrawn, University of Minnesota

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02540616
StatusWithdrawn - Study hypothesis was faulty
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: single, treatment
SponsorUniversity of Minnesota (Other)
ConditionsMal de Debarquement Syndrome
InterventionsTranscranial Electrical Stimulation (Device)
Datesstart 2013-09-01, primary completion 2022-12-01 (estimated), completion 2022-12-01 (estimated), first posted 2015-09-04, last updated 2023-03-16
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Mal de Debarquement Syndrome All trials of Transcranial Electrical Stimulation

-Summary

The goal of this study is to determine whether external neuromodulation using transcranial electrical stimulation (TES) can reduce the perception of self-motion that is experienced by patients with MdDS. Mal de debarquement is translated as the "sickness of disembarkment," and refers to the chronic feeling of rocking dizziness that occurs after exposure to passive motion. A similar form of rocking dizziness can be experienced without a motion trigger in individuals with certain risk factors.

Treatment for MdDS is limited and morbidity is high.The goal of the study is to determine whether TES can suppress the rocking dizziness of MdDS either as a standalone therapy or as an adjunctive therapy to other forms of neuromodulation such as transcranial magnetic stimulation. The investigators will determine the optimal treatment duration and stimulation parameters.

Expand all sections  ·  Collapse all

+Detailed description

Eligible participants who meet study criteria and pass the safety screen will be invited to participate in the study. If TES is used as add-on treatment to repetitive transcranial magnetic stimulation (rTMS), the training for TES application will be done on-site. However, in a portion of the study that does not involve rTMS, remote training will be performed via a webcam provided that a suitable "Study Buddy" is available to assist the participant.

Participants will maintain web-based diaries of their symptoms for up to four weeks prior to treatment with TES. Before the actual treatment sessions are started, the subjects will complete baseline questionnaires online which will be repeated once a week for up to 12 weeks. Over the course of the study, the subjects will also keep a daily log of their sessions such as how many sessions they performed, for how long, and whether they had any side effects with each session.

The studies will include a sham arm, allocated at a ratio of 1:1. On-site studies will involve the application of EEG, MRI, balance, cognitive, and visual/auditory stimulation tests.

+Arms and interventions

ArmTypeInterventionsDescription
Transcranial Electrical Stimulation-RealExperimentalDevice: Transcranial Electrical StimulationThe participant will perform real TES. The forms of TES used in this study will include transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or transcranial random noise stimulation (tRNS). Each stimulation session will last for 20-minutes.
Transcranial Electrical Stimulation-ShamSham comparatorDevice: Transcranial Electrical StimulationThe participant will perform sham TES for 20-minutes. The form of sham TES will depend on the active arm, e.g. if tACS is on the active arm, then the sham tACS will be a different frequency of stimulation. If tDCS is the active arm, then a short ramp up of tDCS followed by a ramp down (about 60-seconds) will be used as the sham arm.
  • Transcranial Electrical Stimulation (Device), also known as Transcranial Direct Current Stimulation (tDCS), Transcranial Alternating Current Stimulation (tACS), Transcranial Random Noise Stimulation (tRNS), Sham Transcranial Stimulation: A form of external neuromodulation using electrodes on the surface of the head. We will be using the TCT tDCS device (www.trans.cranial.com) or devices constructed by our research group or collaborators.

+Outcome measures

Primary outcomes

  • Dizziness Handicap Inventory [10 years]: This is a well validated 100 point self-reported scale with Functional, Physical, and Emotional components.

Secondary outcomes

  • Mal de Debarquement Balance Rating Scale [10 years]: This is a 10 point self-reported scale that assesses the severity of rocking dizziness and its effect on balance function.
  • Hospital Anxiety and Depression Scale [10 years]: This is a well validated 42 point self-reported scale of anxiety and dizziness.

Other outcomes

  • SF-12 [10 years]: Well established Quality of Life Scale
  • Motion Sickness Susceptibility Scale [10 years]: Measures motion sickness susceptibility before and after age 12
  • Neo-Five Factor Inventory [10 years]: Quantifies the five major personality traits
  • Empathy Quotient [10 years]: 40 item online or 20 item abbreviated scale to determine strength of empathic traits
  • Functional Activities Scale [10 years]: Measures comfort with doing some basic activities of daily living
  • Memory Questionnaire [10 years]: Measures subjective impressions of prospective and retrospective memory
  • Multidimensional Fatigue Inventory [10 years]: Measures general, physical, and mental fatigue
  • Edinburgh Handedness Scale [10 years]: Standard measure of handedness

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

1. Age ≥18 years old
2. Willing and capable of interacting with the informed consent process
3. Primary disorder being a persistent perception of motion with no other cause determined after a careful interview.
4. Able to identity a study buddy and provide contact information

Exclusion Criteria:

1. Subjects who cannot comply with study conditions.
2. Active psychiatric condition such as mania or psychosis
3. Unstable medical condition
4. Implanted metal in the head or neck (metal or shrapnel, deep brain stimulators, aneurysm clips, cochlear stimulators, retinal implants, etc). Dental fillings are acceptable.
5. Any active skin disorder that affects skin integrity of the scalp.
6. Pregnant

+Locations (1)

FacilityCityCountryStatus
University of MinnesotaMinneapolis, MinnesotaUnited States

+Publications

  • Results publication: Cha YH, Gleghorn D, Doudican BC. Double-blind randomized N-of-1 trial of transcranial alternating current stimulation for mal de debarquement syndrome. PLoS One. 2022 Feb 4;17(2):e0263558. doi: 10.1371/journal.pone.0263558. eCollection 2022. PMID 35120184

+Investigators